Yasutaka Takagi

572 total citations
20 papers, 475 citations indexed

About

Yasutaka Takagi is a scholar working on Ophthalmology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Yasutaka Takagi has authored 20 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Ophthalmology, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Molecular Biology. Recurrent topics in Yasutaka Takagi's work include Glaucoma and retinal disorders (11 papers), Retinal Diseases and Treatments (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Yasutaka Takagi is often cited by papers focused on Glaucoma and retinal disorders (11 papers), Retinal Diseases and Treatments (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Yasutaka Takagi collaborates with scholars based in Japan and United States. Yasutaka Takagi's co-authors include Soichi Miwa, Τοmoh Masaki, Takeshi Matsugi, Hideaki Hara, Aiji Sakamoto, Atsushi Shimazaki, Haruaki Ninomiya, Tadashi Nakajima, Masaaki Kageyama and B’Ann T. Gabelt and has published in prestigious journals such as Journal of Biological Chemistry, Brain Research and Journal of Neurochemistry.

In The Last Decade

Yasutaka Takagi

19 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasutaka Takagi Japan 10 221 187 87 73 70 20 475
Charles E. Protzman United States 13 189 0.9× 232 1.2× 113 1.3× 104 1.4× 27 0.4× 19 657
Carlo Nucci Italy 17 444 2.0× 455 2.4× 44 0.5× 104 1.4× 112 1.6× 35 912
Andrea Matteucci Italy 15 314 1.4× 171 0.9× 14 0.2× 162 2.2× 62 0.9× 31 629
А. Ж. Фурсова Russia 14 390 1.8× 276 1.5× 16 0.2× 185 2.5× 89 1.3× 79 695
Roshana Vander Wall Australia 13 254 1.1× 208 1.1× 17 0.2× 103 1.4× 82 1.2× 23 462
Mónica G. Ilincheta de Boschero Argentina 12 324 1.5× 40 0.2× 19 0.2× 133 1.8× 23 0.3× 22 540
D Dettmer Germany 13 343 1.6× 52 0.3× 13 0.1× 61 0.8× 30 0.4× 35 535
Laurence M. Rapp United States 11 428 1.9× 286 1.5× 9 0.1× 60 0.8× 79 1.1× 14 676
О. С. Кожевникова Russia 16 393 1.8× 281 1.5× 7 0.1× 184 2.5× 66 0.9× 42 661
Joyshree Biswas India 13 163 0.7× 89 0.5× 8 0.1× 92 1.3× 36 0.5× 16 467

Countries citing papers authored by Yasutaka Takagi

Since Specialization
Citations

This map shows the geographic impact of Yasutaka Takagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasutaka Takagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasutaka Takagi more than expected).

Fields of papers citing papers by Yasutaka Takagi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasutaka Takagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasutaka Takagi. The network helps show where Yasutaka Takagi may publish in the future.

Co-authorship network of co-authors of Yasutaka Takagi

This figure shows the co-authorship network connecting the top 25 collaborators of Yasutaka Takagi. A scholar is included among the top collaborators of Yasutaka Takagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasutaka Takagi. Yasutaka Takagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanito, Masaki, et al.. (2023). Factors Associated with Topical Medication Instillation Failure in Glaucoma: VRAMS-QPiG Study. Advances in Therapy. 40(11). 4907–4918. 4 indexed citations
2.
Yoshida, Takeshi, Yasutaka Takagi, Tae Igarashi-Yokoi, & Kyoko Ohno‐Matsui. (2023). Efficacy of lutein supplements on macular pigment optical density in highly myopic individuals: A randomized controlled trial. Medicine. 102(12). e33280–e33280. 4 indexed citations
3.
Kaidzu, Sachiko, et al.. (2020). Effects of French maritime pine bark/bilberry fruit extracts on intraocular pressure for primary open-angle glaucoma. Journal of Clinical Biochemistry and Nutrition. 68(1). 67–72. 9 indexed citations
4.
Yamada, Masakazu, et al.. (2020). Cost-effectiveness and budget impact analysis of a patient visit support system for blindness reduction in Japanese patients with glaucoma. Journal of Medical Economics. 23(11). 1293–1301. 3 indexed citations
5.
Takagi, Yasutaka, et al.. (2018). Ocular hypotensive effects of prostaglandin analogs in Japanese patients with normal-tension glaucoma: a literature review. Clinical ophthalmology. Volume 12. 1837–1844. 7 indexed citations
7.
Yoshino, Kyoji, et al.. (2009). Anti-Diabetic Activity of a Leaf Extract Prepared fromSalacia reticulatain Mice. Bioscience Biotechnology and Biochemistry. 73(5). 1096–1104. 25 indexed citations
8.
Takagi, Yasutaka, Tadashi Nakajima, Atsushi Shimazaki, et al.. (2004). Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug. Experimental Eye Research. 78(4). 767–776. 125 indexed citations
9.
Takagi, Yasutaka, et al.. (2004). Effects of Bunazosin Hydrochloride on Ciliary Muscle Constriction and Matrix Metalloproteinase Activities. Journal of Glaucoma. 13(4). 312–318. 6 indexed citations
10.
Shimazaki, Atsushi, Masaki Ichikawa, Takeshi Matsugi, et al.. (2004). New Ethacrynic Acid Derivatives as Potent Cytoskeletal Modulators in Trabecular Meshwork Cells. Biological and Pharmaceutical Bulletin. 27(6). 846–850. 6 indexed citations
11.
Takagi, Yasutaka, Takeshi Matsugi, Masaaki Kageyama, et al.. (2003). Potent Intraocular Pressure Reducing Effects of AFP-168, a New Prostanoid FP Receptor Agonist. Investigative Ophthalmology & Visual Science. 44(13). 4407–4407. 1 indexed citations
12.
Ishibashi, Takeshi, Yasutaka Takagi, Kazuhiko Mori, et al.. (2002). cDNA microarray analysis of gene expression changes induced by dexamethasone in cultured human trabecular meshwork cells.. PubMed. 43(12). 3691–7. 57 indexed citations
13.
Takagi, Yasutaka, Yasuhiro Gon, Tatemi Todaka, et al.. (1998). Expression of thioredoxin is enhanced in atherosclerotic plaques and during neointima formation in rat arteries.. PubMed. 78(8). 957–66. 70 indexed citations
14.
Takagi, Yasutaka, Haruaki Ninomiya, Aiji Sakamoto, Soichi Miwa, & Τοmoh Masaki. (1995). Structural Basis of G Protein Specificity of Human Endothelin Receptors. Journal of Biological Chemistry. 270(17). 10072–10078. 77 indexed citations
16.
Koshimura, Kunio, Yasutaka Takagi, Soichi Miwa, et al.. (1995). Characterization of a Dopamine‐Releasing Action of 6Rlerythro‐Tetrahydrobiopterin: Comparison with a 6S‐Form. Journal of Neurochemistry. 65(2). 827–830. 16 indexed citations
17.
Miwa, Soichi, Kunio Koshimura, Yoshinori Akiyama, et al.. (1994). Ischemia-induced changes in catecholamine release and their mechanisms: a study using cultured bovine adrenal chromaffin cells. Brain Research. 643(1-2). 266–275. 8 indexed citations
18.
Koshimura, Kunio, et al.. (1993). Enhancement of acetylcholine release in the hippocampus by 6R--erythro-5,6,7,8-tetrahydrobiopterin is mediated by 5-hydroxytryptamine. Brain Research. 607(1-2). 255–260. 6 indexed citations
19.
Koshimura, Kunio, Yoshinori Akiyama, Akihiro Ito, et al.. (1992). Regulation of acetylcholine release in vivo from rat hippocampus by monoamines as revealed by novel column-switching HPLC with electrochemical detection. Brain Research. 572(1-2). 340–344. 24 indexed citations
20.
Takagi, Yasutaka, et al.. (1992). 6R-L-erythro-5,6,7,8-Tetrahydrobiopterin, a cofactor for tyrosine hydroxylase, increases dopamine release from rat striatal slices. The Japanese Journal of Pharmacology. 58. 370–370.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026